To our knowledge, several of the selected biomarkers in active compared to inactive JIA in our study, such as CXCL11, lymphotoxin alpha (LT-alpha, formerly referred to as TNF-beta), and IL20, have not previously been targets for further investigations in serum in young individuals with non-systemic JIA. The gene discussed is IL20; the disease is juvenile idiopathic arthritis.